T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$784M |
| 2 |
Danaher
DHR
|
+$764M |
| 3 |
Intuit
INTU
|
+$679M |
| 4 |
PTC
PTC
|
+$559M |
| 5 |
Avantor
AVTR
|
+$447M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CrowdStrike
CRWD
|
+$766M |
| 2 |
Spotify
SPOT
|
+$730M |
| 3 |
KKR & Co
KKR
|
+$587M |
| 4 |
Goldman Sachs
GS
|
+$531M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$515M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 20.33% |
| 3 | Industrials | 12.32% |
| 4 | Consumer Discretionary | 11.88% |
| 5 | Financials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Alamo Group
ALG
$2B
| $15.3M | 0.01% |
88,643
-510,660
| -85% | -$99.6M |
|
527
Chewy
CHWY
$9.15B
| $15.2M | 0.01% |
557,570
+399,405
| +253% | +$7.61M |
|
528
Ibotta
IBTA
$730M
| $15M | 0.01% |
+199,964
| New | +$18.6M |
|
|
SLRN
529
DELISTED
ACELYRIN
SLRN
| $14.8M | 0.01% |
3,352,307
+1,232,716
| +58% | +$5.78M |
|
530
Williams-Sonoma
WSM
$28.9B
| $14.7M | 0.01% |
104,312
-89,212
| -46% | -$13.3M |
|
531
Abbott
ABT
$193B
| $14.6M | 0.01% |
140,542
+40,648
| +41% | +$4.31M |
|
532
Metropolitan Bank Holding Corp
MCB
$1.18B
| $13.1M | 0.01% |
311,894
-329,765
| -51% | -$13.2M |
|
533
MYR Group
MYRG
$5.19B
| $13.1M | 0.01% |
96,575
-130
| -0.1% | -$20.3K |
|
534
American Tower
AMT
$80.3B
| $13.1M | 0.01% |
67,202
+14,987
| +29% | +$2.8M |
|
535
Knowles
KN
$3.31B
| $12.8M | 0.01% |
743,918
-1,136,134
| -60% | -$19.1M |
|
536
WEC Energy
WEC
$35.7B
| $12.5M | 0.01% |
158,889
-2,170,778
| -93% | -$176M |
|
|
SHYF
537
DELISTED
The Shyft Group
SHYF
| $12.3M | 0.01% |
1,036,225
-405,300
| -28% | -$4.87M |
|
538
SBA Communications
SBAC
$19.6B
| $11.9M | 0.01% |
60,787
-1,117,572
| -95% | -$221M |
|
539
BRC Inc
BRCC
$222M
| $11.7M | 0.01% |
+1,908,354
| New | +$9.92M |
|
|
ENFN
540
DELISTED
Enfusion, Inc.
ENFN
| $11.7M | 0.01% |
1,371,472
+491,750
| +56% | +$4.5M |
|
541
Elevance Health
ELV
$87B
| $11.5M | 0.01% |
21,211
+5,114
| +32% | +$2.7M |
|
|
STR
542
DELISTED
Sitio Royalties
STR
| $11.4M | 0.01% |
+484,209
| New | +$11.4M |
|
543
RxSight
RXST
$291M
| $11.4M | 0.01% |
189,027
-583,192
| -76% | -$33.3M |
|
544
Atlanta Braves Holdings Series B
BATRK
$3.45B
| $11.1M | 0.01% |
+282,544
| New | +$11M |
|
545
West Fraser Timber
WFG
$5.53B
| $10M | 0.01% |
130,681
-11,312
| -8% | -$898K |
|
546
Unifirst Corp
UNF
$5.24B
| $10M | 0.01% |
58,533
-38,886
| -40% | -$6.27M |
|
547
Accenture
ACN
$110B
| $9.55M | 0.01% |
31,486
+24,734
| +366% | +$7.58M |
|
548
Palomar
PLMR
$3.39B
| $9.4M | 0.01% |
115,873
-32,062
| -22% | -$2.61M |
|
549
Alpha Metallurgical Resources
AMR
$2B
| $8.67M | 0.01% |
30,894
-105
| -0.3% | -$32.5K |
|
550
Sana Biotechnology
SANA
$1.11B
| $8.51M | 0.01% |
1,558,229
-3,243,618
| -68% | -$25.8M |
|
Similar funds
T. Rowe Price Investment Management's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Investment Management held 668 positions worth $158B, down 3.1% from $163B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
T. Rowe Price Investment Management's Q2 2024 filing shows 48 new, 292 increased, 275 reduced and 48 closed positions. Its largest new stake was Broadcom: 5,594,890 shares worth $898M. The largest sale was CrowdStrike, an estimated $766M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
- T. Rowe Price Investment Management's largest Q2 2024 buy was Broadcom: 5,594,890 shares worth $898M.
- T. Rowe Price Investment Management added most to Danaher in Q2 2024, an estimated $764M increase.
- T. Rowe Price Investment Management's biggest Q2 2024 reduction was CrowdStrike, cutting an estimated $766M.
- T. Rowe Price Investment Management fully exited CATALENT, INC. in Q2 2024, selling an estimated $231M.
- T. Rowe Price Investment Management's ten largest holdings make up 17% of its $158B portfolio in Q2 2024.
- T. Rowe Price Investment Management opened 48 new positions and closed 48 in Q2 2024.
- T. Rowe Price Investment Management's portfolio value fell 3.1% quarter-over-quarter to $158B.
Based on T. Rowe Price Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.